These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6231137)

  • 1. Micromethod for phosphonoformate inhibition assay of hepatitis B viral DNA polymerase.
    Lin HJ; Wu PC; Lai CL; Chak W
    Clin Chem; 1984 Apr; 30(4):549-52. PubMed ID: 6231137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphonoformic acid-inhibitable nucleotide incorporation as a measure of hepatitis B viral DNA polymerase activity.
    Lin HJ; Kwan JP; Wu PC; Chak W
    J Med Virol; 1983; 12(1):61-70. PubMed ID: 6225836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hepatitis-B-virus DNA polymerase by phosphonoformate: studies on its mode of action.
    Hess G; Arnold W; Meyer zum Büschenfelde KH
    J Med Virol; 1980; 5(4):309-16. PubMed ID: 6453206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No in vivo effect of trisodium phosphonoformate on woodchuck hepatitis virus production.
    Nordenfelt E; Widell A; Hansson BG; Löfgren B; Möller-Nielsen C; Oberg B
    Acta Pathol Microbiol Immunol Scand B; 1982 Dec; 90(6):449-51. PubMed ID: 6220563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisodium phosphonoformate inhibits woodchuck hepatitis virus associated DNA polymerase.
    Nordenfelt E; Werner B
    Acta Pathol Microbiol Scand B; 1980 Jun; 88(3):183-4. PubMed ID: 6449828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1982; 19(3):387-415. PubMed ID: 6201932
    [No Abstract]   [Full Text] [Related]  

  • 7. Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
    Cheng YC; Grill S; Derse D; Chen JY; Caradonna SJ; Connor K
    Biochim Biophys Acta; 1981 Jan; 652(1):90-8. PubMed ID: 6260189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of properties of woodchuck hepatitis virus and human hepatitis B virus endogenous DNA polymerases.
    Hantz O; Ooka T; Vitvitski L; Pichoud C; Trepo C
    Antimicrob Agents Chemother; 1984 Feb; 25(2):242-6. PubMed ID: 6231885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of Epstein-Barr virus DNA polymerase with aphidicolin, phosphonoformate and 5'-GMP.
    Li JS; Cheng YC
    Virus Genes; 1988 Jul; 1(4):369-75. PubMed ID: 2852412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks.
    Sherker AH; Hirota K; Omata M; Okuda K
    Gastroenterology; 1986 Oct; 91(4):818-24. PubMed ID: 2943628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.
    Margalith M; Falk H; Panet A
    Mol Cell Biochem; 1982 Mar; 43(2):97-103. PubMed ID: 6178013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cytomegalovirus late antigens by phosphonoformate.
    Wahren B; Oberg B
    Intervirology; 1980; 12(6):335-9. PubMed ID: 6244238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1989; 40(2):213-85. PubMed ID: 2543994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of inhibition of Epstein-Barr virus replication by phosphonoformic acid.
    Datta AK; Hood RE
    Virology; 1981 Oct; 114(1):52-9. PubMed ID: 6269292
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of hepatitis B virus DNA polymerase.
    Goto Y; Yamashita T; Arens M; Takahashi T; Hashimoto T
    Jpn J Med Sci Biol; 1984 Feb; 37(1):9-18. PubMed ID: 6204081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutually exclusive inhibition of herpesvirus DNA polymerase by aphidicolin, phosphonoformate, and acyclic nucleoside triphosphates.
    Frank KB; Cheng YC
    Antimicrob Agents Chemother; 1985 Apr; 27(4):445-8. PubMed ID: 2988429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sodium phosphonoformate on blood group antibody detection.
    Hunt AF; Jones MT; Howkins GJ
    Vox Sang; 1986; 51(3):231-2. PubMed ID: 2949433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.
    Sandstrom EG; Kaplan JC; Byington RE; Hirsch MS
    Lancet; 1985 Jun; 1(8444):1480-2. PubMed ID: 2409414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.
    Goodrich JM; Lee KW; Hinze HC
    Arch Virol; 1980; 66(3):261-4. PubMed ID: 6449917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of RNA- and DNA-dependent duck hepatitis B virus DNA polymerase activity by nucleoside and pyrophosphate analogs.
    Löfgren B; Nordenfelt E; Oberg B
    Antiviral Res; 1989 Dec; 12(5-6):301-10. PubMed ID: 2483879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.